[go: up one dir, main page]

EP4581948A1 - Matériau aérosolisable pour utilisation dans un article - Google Patents

Matériau aérosolisable pour utilisation dans un article Download PDF

Info

Publication number
EP4581948A1
EP4581948A1 EP24150733.4A EP24150733A EP4581948A1 EP 4581948 A1 EP4581948 A1 EP 4581948A1 EP 24150733 A EP24150733 A EP 24150733A EP 4581948 A1 EP4581948 A1 EP 4581948A1
Authority
EP
European Patent Office
Prior art keywords
aerosolisable material
amount
present
aerosolisable
terpene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24150733.4A
Other languages
German (de)
English (en)
Inventor
Oriol STROPHAIR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bt De Investments Inc
Original Assignee
Bt De Investments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bt De Investments Inc filed Critical Bt De Investments Inc
Priority to EP24150733.4A priority Critical patent/EP4581948A1/fr
Priority to PCT/IB2025/050162 priority patent/WO2025149901A1/fr
Publication of EP4581948A1 publication Critical patent/EP4581948A1/fr
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/42—Cartridges or containers for inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0024—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with an on-off output signal, e.g. from a switch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0039—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0211—Ceramics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
    • A61M2205/121—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit interface between cassette and base
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
    • A61M2205/123—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with incorporated reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
    • A61M2205/127—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with provisions for heating or cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/36—General characteristics of the apparatus related to heating or cooling
    • A61M2205/3653—General characteristics of the apparatus related to heating or cooling by Joule effect, i.e. electric resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated

Definitions

  • the present invention relates to an aerosolisable material, as well as an article comprising said aerosolisable material and systems using and incorporating said article.
  • the aerosolisable material in a certain way. For example, it may be preferable to formulate aerosolisable materials so as to produce an aerosol with a particular profile.
  • an aerosolisable material comprising at least one terpene, and benzyl alcohol or functional derivatives thereof.
  • an article comprising an aerosolisable material, the aerosolisable material comprising at least one terpene, and benzyl alcohol or functional derivatives thereof.
  • Figure 1 - Provides a schematic overview of an article, aerosol delivery device and system as described herein.
  • an aerosolisable material comprising at least one terpene, and benzyl alcohol or functional derivatives thereof.
  • An example of functional derivatives of the benzyl alcohol is where the benzyl group is further substituted with a C 1 -C 3 alkyl group.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 4%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 5%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 6%w/w to 20%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 7%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 8%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 9%w/w to 20%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 10%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 11%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 12%w/w to 20%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 13%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 14%w/w to 20%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 15%w/w to 20%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 15%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 14%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 13%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1 %w/w to 12%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 11%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 10%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 9%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 8%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 7%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 6%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 6%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 4%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of from 1%w/w to 3%w/w based on the total weight of the aerosolisable material.
  • the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of about 9%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of about 1%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of about 10%w/w based on the total weight of the aerosolisable material. In one embodiment, the aerosolisable material comprises benzyl alcohol (or functional derivatives thereof) in an amount of about 11%w/w based on the total weight of the aerosolisable material.
  • Ambient temperature in the context of the present disclosure means 18 to 25°C.
  • the at least one terpene may be added as part of one or more terpene "blocks".
  • a block is a collection of terpenes which are added to an aerosolisable formulation.
  • the terpene block acts as a viscosity modifier.
  • the addition of the terpene block may result in an overall reduction in the viscosity of the aerosolisable material.
  • the terpenes in the terpene block are selected from the group consisting of alpha-humulene, valencene, nerolidol, alpha-bisabolol, guaiol, caryophyllene oxide, limonene, terpinolene, beta-myrcene, beta-ocimene, camphene, alpha-pinene, beta-pinene, linalyl acetate, geranyl acetate, beta-citronellol, linalool, alpha-terpineol, eucalyptol (1,8-cineole), fenchol and camphor.
  • the terpenes in the terpene block are selected from the group consisting of limonene, terpinolene, beta-myrcene, beta-ocimene, camphene, alpha-pinene, beta-pinene, linalyl acetate, geranyl acetate, beta-citronellol, linalool, alpha-terpineol, eucalyptol (1,8-cineole), fenchol and camphor.
  • the terpene block preferably comprises limonene, linalyl acetate, beta-caryophyllene, beta-citronellol and linalool.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.1%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.2%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.3%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.4%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.6%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.7%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.8%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 0.9%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of at least 1.0%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 1.1%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of no greater than 5.0%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 4.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 4.0%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of at least 3.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 3.0%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of at least 2.5%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.1 to 5.0%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.1 to 4.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.1 to 4.0%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.1 to 1.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.2 to 1.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.3 to 1.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.4 to 1.5%w/w based on the total weight of the aerosolisable material.
  • the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.8 to 1.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of from 0.9 to 1.5%w/w based on the total weight of the aerosolisable material. In one embodiment, the terpene or the terpene block is present in the aerosolisable material in an amount of from 1.0 to 1.5%w/w based on the total weight of the aerosolisable material.
  • the total amount of the terpene or terpene block present in the aerosolisable material is up to about 60 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 50 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 40 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 30 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 20 mg/ml.
  • the total amount of the terpene or terpene block present in the aerosolisable material is up to about 15 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 14 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 13 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 12 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 11 mg/ml. In one embodiment, the total amount of the terpene or terpene block present in the aerosolisable material is up to about 10 mg/ml.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
EP24150733.4A 2024-01-08 2024-01-08 Matériau aérosolisable pour utilisation dans un article Pending EP4581948A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP24150733.4A EP4581948A1 (fr) 2024-01-08 2024-01-08 Matériau aérosolisable pour utilisation dans un article
PCT/IB2025/050162 WO2025149901A1 (fr) 2024-01-08 2025-01-07 Matériau aérosolisable destiné à être utilisé dans un article

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP24150733.4A EP4581948A1 (fr) 2024-01-08 2024-01-08 Matériau aérosolisable pour utilisation dans un article

Publications (1)

Publication Number Publication Date
EP4581948A1 true EP4581948A1 (fr) 2025-07-09

Family

ID=89535756

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24150733.4A Pending EP4581948A1 (fr) 2024-01-08 2024-01-08 Matériau aérosolisable pour utilisation dans un article

Country Status (2)

Country Link
EP (1) EP4581948A1 (fr)
WO (1) WO2025149901A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106617266A (zh) * 2016-12-19 2017-05-10 深圳瀚星翔科技有限公司 电子烟烟液
CN116439403A (zh) * 2023-05-25 2023-07-18 常州市派腾电子技术服务有限公司 一种雾化液及雾化器和气溶胶发生装置
JP2023106471A (ja) * 2019-05-22 2023-08-01 大日本除蟲菊株式会社 発泡性洗剤組成物
CN116869211A (zh) * 2023-07-13 2023-10-13 深圳市吉迩科技有限公司 一种风味组合物及其应用的雾化液

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106617266A (zh) * 2016-12-19 2017-05-10 深圳瀚星翔科技有限公司 电子烟烟液
JP2023106471A (ja) * 2019-05-22 2023-08-01 大日本除蟲菊株式会社 発泡性洗剤組成物
CN116439403A (zh) * 2023-05-25 2023-07-18 常州市派腾电子技术服务有限公司 一种雾化液及雾化器和气溶胶发生装置
CN116869211A (zh) * 2023-07-13 2023-10-13 深圳市吉迩科技有限公司 一种风味组合物及其应用的雾化液

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "DARK SIDE OF THE MOON FULL-SPECTRUM CANNABIS OIL VAPE CARTRIDGE", 12 September 2017 (2017-09-12), pages 1 - 1, XP093139065, Retrieved from the Internet <URL:https://www.trychemistry.com/product-page/dark-side-of-the-moon> [retrieved on 20240307] *
ELSOHLY, M.A.RADWAN, M.M.GUL, VV.CHANDRA, S.GALAL, A.: "Phytochemistry of Cannabis sativa L", PROG. CHEM. ORG. NAT. PROD., vol. 103, 2017, pages 1 - 36
IBEAS BIH, C.CHEN, T.NUNN, A. V. VV. ET AL., MOLECULAR TARGETS OF CANNABIDIOL IN NEUROLOGICAL DISORDERS. NEUROTHERAPEUTICS, vol. 12, 2015, pages 699 - 730
LEIGH NOEL J. ET AL: "Acute Effect of Electronic Cigarette-Generated Aerosol From Flavored CBD-Containing Refill Solutions on Human Bronchial Epithelial Cells", FRONTIERS IN PHYSIOLOGY, vol. 11, 21 October 2020 (2020-10-21), CH, XP093138578, ISSN: 1664-042X, DOI: 10.3389/fphys.2020.592321 *

Also Published As

Publication number Publication date
WO2025149901A1 (fr) 2025-07-17

Similar Documents

Publication Publication Date Title
AU2020364112B2 (en) Aerosolisable material
AU2023270189A1 (en) Article
EP4581948A1 (fr) Matériau aérosolisable pour utilisation dans un article
AU2021347760B2 (en) Formulation
EP4581947A1 (fr) Matériau aérosolisable pour utilisation dans un article
EP4581944A1 (fr) Matériau aérosolisable pour utilisation dans un article
EP4581943A1 (fr) Matériau aérosolisable pour utilisation dans un article
EP4609729A1 (fr) Matériau aérosolisable pour utilisation dans un article
US20250287987A1 (en) Aerosolisable material
CA3154289C (fr) Article aux fins d&#39;utilisation avec un systeme d&#39;aerosol comprenant une matiere vaporisable et une meche formee d&#39;un materiau fritte
US12439951B2 (en) Aerosolizable material with cannabinoid and carrier constituent
CA3154291C (fr) Materiau aerosolisable
AU2020364111B2 (en) Aerosolisable material
KR20230066010A (ko) 패키징된 포뮬레이션

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR